Abstract

To counter HIV latency, it is important to develop a better understanding of the full range of host factors promoting latency. Their identification could suggest new strategies to reactivate latent proviruses and subsequently kill the host cells (“shock and kill”), or to permanently silence these latent proviruses (“block and lock”). We recently developed a screening strategy termed “Reiterative Enrichment and Authentication of CRISPRi Targets” (REACT) that can unambiguously identify host genes promoting HIV latency, even in the presence of high background “noise” produced by the stochastic nature of HIV reactivation. After applying this strategy in four cell lines displaying different levels of HIV inducibility, we identified FTSJ3, TMEM178A, NICN1 and the Integrator Complex as host genes promoting HIV latency. shRNA knockdown of these four repressive factors significantly enhances HIV expression in primary CD4 T cells, and active HIV infection is preferentially found in cells expressing lower levels of these four factors. Mechanistically, we found that downregulation of these newly identified host inhibitors stimulates different stages of RNA Polymerase II-mediated transcription of HIV-1. The identification and validation of these new host inhibitors provide insight into the novel mechanisms that maintain HIV latency even when cells are activated and undergo cell division.

Highlights

  • Development of successful HIV cure strategies will be propelled by better understanding the mechanisms that maintain HIV-1 proviruses in a state of latency [1]

  • We conducted genome-wide CRISPR interference (CRISPRi) screens in multiple latently infected cell lines where each cell line displayed a different depth of latency as assessed by responsiveness to latency reversing agents

  • Construction of Doxycycline-Inducible CRISPRi Jurkat cell lines latently infected with HIV-GFP Exhibiting different levels of spontaneous and induced reactivation

Read more

Summary

Introduction

Development of successful HIV cure strategies will be propelled by better understanding the mechanisms that maintain HIV-1 proviruses in a state of latency [1]. Many HIV-1 cure-related studies have focused on the “shock and kill” approach that aims to re-activate latent HIV-1 with latency reversing agents (LRAs) and to eliminate the reactivated cells either through a viral cytopathic effect or as a result of immune cell-mediated clearance [19,20,21,22]. A variety of LRAs have been tested, including protein kinase C activators, histone deacetylase inhibitors, and bromodomain inhibitors [24]. These agents only re-activate a small fraction of the pool of latently infected cells [10,25], and none have detectably reduced the size of the latent reservoir in vivo [26,27]. Identifying the full set of host genes promoting HIV-1 latency could provide new and improved approaches for furthering both the “shock and kill” and “block and lock” therapeutic strategies

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call